Britain on Friday approved the use of the single shot Johnson & Johnson coronavirus vaccine, the Medicines and Healthcare products Regulatory Agency (MHRA) announced.
“This is a further boost to the UK’s hugely successful vaccination programme, which has already saved over 13,000 lives, and means that we now have four safe and effective vaccines approved to help protect people from this awful virus,” said Health Secretary Matt Hancock.
The government hopes the single-dose jab “will play an important role in the months to come”, he added, as young people come forward for their vaccinations amid concern over the rise of the so-called Indian variant.
Britain has ordered 20 million doses of the vaccine.
The European Medicines Agency said in April that a warning about unusual blood clots with low blood platelet count should be added to its product information following cases in the United States.
The vaccine was found to be 72 percent effective in preventing moderate to severe coronavirus infection, according to a US trial.
Britain has administered more than 62 million shots so far, mainly using the Pfizer and AstraZeneca vaccines. It has also approved the use of the Moderna vaccine.
After months of falling cases, infections have started to rise again due to the emergence of the Indian variant, which has put in doubt plans for a full reopening of the country on June 21.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…